Literature DB >> 22321037

Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.

Young Koog Cheon1, Tae Yoon Lee, Seung Min Lee, Jung Yoon Yoon, Chan Sup Shim.   

Abstract

OBJECTIVES: This study aimed to determine longterm outcomes and factors associated with increased survival after photodynamic therapy (PDT) compared with endoscopic biliary drainage alone in patients presenting with advanced hilar cholangiocarcinoma (CC).
METHODS: A retrospective analysis of the institutional database identifying all patients who presented with a diagnosis of hilar CC between December 1999 and January 2011 was conducted.
RESULTS: Of the 232 patients identified, 72 (31%) were treated with PDT (Group A) and 71 (31%) were treated with endoscopic biliary drainage alone (Group B). Median survival was 9.8 months [95% confidence interval (CI) 7.42-12.25] in Group A and 7.3 months (95% CI 4.79-9.88) in Group B (P= 0.029). On multivariate analysis, biliary drainage without PDT (P= 0.025) and higher T-stage (P= 0.002) were significant predictors of shorter survival in all patients. In a subgroup analysis of patients in the PDT group, lower pre-PDT bilirubin level (P= 0.005), multiple PDT treatments (P= 0.044) and shortened time to treatment after diagnosis (P= 0.013) were significant predictors of improved survival. Median metal stent patency was longer in Group A than in Group B (215 days vs. 181 days; P= 0.018).
CONCLUSIONS: Photodynamic therapy with stenting resulted in longer survival than stenting alone. Early PDT after diagnosis and multiple PDT treatments were shown to have survival benefits. Metal stent patency was longer in patients receiving PDT. Higher T-stage appears to be a predictor of early mortality in advanced bile duct cancer treated with PDT.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22321037      PMCID: PMC3371201          DOI: 10.1111/j.1477-2574.2011.00424.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  27 in total

1.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.

Authors:  Franz Ludwig Dumoulin; Thomas Gerhardt; Sybille Fuchs; Christian Scheurlen; Michael Neubrand; Günter Layer; Tilman Sauerbruch
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

2.  [Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage].

Authors:  Young Koog Cheon; Young Deok Cho; Seung Hoon Baek; Sang Woo Cha; Jong Ho Moon; Yun Soo Kim; Jun Seong Lee; Moon Sung Lee; Chan Sup Shim; Boo Sung Kim
Journal:  Korean J Gastroenterol       Date:  2004-11

Review 3.  Recent advances in the management of cholangiocarcinomas.

Authors:  J N Vauthey; L H Blumgart
Journal:  Semin Liver Dis       Date:  1994-05       Impact factor: 6.115

4.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

5.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

6.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

Review 7.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

8.  "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention.

Authors:  D R Farley; A L Weaver; D M Nagorney
Journal:  Mayo Clin Proc       Date:  1995-05       Impact factor: 7.616

9.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Todd H Baron; Navtej S Buttar; Louis-Michel Wongkeesong; Lewis R Roberts; Andrew J LeRoy; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Clin Gastroenterol Hepatol       Date:  2007-06       Impact factor: 11.382

View more
  20 in total

1.  Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications.

Authors:  Werner Dolak; Hubert Schwaighofer; Brigitte Hellmich; Bernhard Stadler; Georg Spaun; Wolfgang Plieschnegger; Arnold Hebenstreit; Jutta Weber-Eibel; Franz Siebert; Klaus Emmanuel; Peter Knoflach; Michael Gschwantler; Wolfgang Vogel; Michael Trauner; Andreas Püspök
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

2.  Emerging local ablative therapies for unresectable perihilar cholangiocarinoma: Time for re-appraisal.

Authors:  Pim B Olthof; Robert J Coelen; Michal Heger; Heinz-Josef Klümpen; Erik A Rauws; Thomas M van Gulik
Journal:  United European Gastroenterol J       Date:  2017-01-12       Impact factor: 4.623

Review 3.  Endoscopic treatment options for cholangiocarcinoma.

Authors:  Linda Ann Hou; Jacques Van Dam
Journal:  Hepat Oncol       Date:  2014-03-20

Review 4.  Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.

Authors:  Dushant S Uppal; Andrew Y Wang
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

5.  Endoscopic treatment of malignant biliary strictures.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Curr Gastroenterol Rep       Date:  2015-01

6.  Current status of photodynamic therapy for bile duct cancer.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim
Journal:  Clin Endosc       Date:  2013-01-31

Review 7.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

Review 8.  Management of perihilar cholangiocarcinoma in the era of multimodal therapy.

Authors:  Vicente Valero; David Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2012-08       Impact factor: 3.869

9.  Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim; Young Deok Cho
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

Review 10.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.